|
CEP120 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.32820000021373E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.78700000019738E-07 |
| Normal-vs-Stage2 |
8.424500E-02 |
| Normal-vs-Stage3 |
3.551900E-02 |
| Normal-vs-Stage4 |
3.363400E-01 |
| Stage1-vs-Stage2 |
3.769000E-01 |
| Stage1-vs-Stage3 |
2.011000E-01 |
| Stage1-vs-Stage4 |
3.090400E-01 |
| Stage2-vs-Stage3 |
8.800400E-01 |
| Stage2-vs-Stage4 |
8.126600E-01 |
| Stage3-vs-Stage4 |
8.726800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.66520000000059E-06 |
| Normal-vs-AfricanAmerican |
1.204090E-04 |
| Normal-vs-Asian |
1.846160E-02 |
| Caucasian-vs-AfricanAmerican |
7.955200E-01 |
| Caucasian-vs-Asian |
9.519400E-01 |
| AfricanAmerican-vs-Asian |
8.801000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.82430000392498E-08 |
| Normal-vs-Female |
4.250200E-02 |
| Male-vs-Female |
9.063800E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.984600E-04 |
| Normal-vs-Extreme_Weight |
1.80150000472779E-08 |
| Normal-vs-Obese |
7.940400E-03 |
| Normal-vs-Extreme_Obese |
3.58069999994992E-06 |
| Normal_Weight-vs-Extreme_Weight |
4.687400E-01 |
| Normal_Weight-vs-Obese |
2.995800E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.587600E-01 |
| Extreme_Weight-vs-Obese |
3.384200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.234000E-01 |
| Obese-vs-Extreme_Obese |
8.412300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.376800E-03 |
| Normal-vs-Age(41-60Yrs) |
1.262250E-03 |
| Normal-vs-Age(61-80Yrs) |
5.12600000224239E-08 |
| Normal-vs-Age(81-100Yrs) |
6.150100E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.487000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.083200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.095000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.032300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.827800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.065400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.04229999964289E-07 |
| Normal-VS-Type2 PRCC |
1.199390E-03 |
| Normal-VS-KIRP CIMP |
2.480200E-02 |
| Normal-VS-Unclassified PRCC |
1.652960E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.989200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.456000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.449040E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.618600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.201800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.851800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62295999999174E-05 |
| Normal-vs-N1 |
3.308400E-01 |
| Normal-vs-N2 |
1.223650E-02 |
| N0-vs-N1 |
2.919500E-02 |
| N0-vs-N2 |
9.399800E-01 |
| N1-vs-N2 |
3.038800E-01 |
|
|
